Advertise
NEWSLETTER
IBIO-610 combined with sema...
Cognition Therapeutics wins...
United Therapeutics present...
Function, Google partner to...
Immorta Bio develops AI-des...
IBIO-610 combined with sema...
Cognition Therapeutics wins...
United Therapeutics present...
Function, Google partner to...
Immorta Bio develops AI-des...
Features

‘Show me the error bars before you sell me longevity’

Oura and Xella connect wearable data to women’s healthspan

Building the infrastructure for preventive care

As health data multiplies, Longevitix is building a physician-led AI layer designed to turn complexity into

Menopause is a brain health story, too

$617 billion longevity biotech market takes shape

Longevity.Technology wants to make longevity make sense

Longevity.Technology wants to make longevity make sense

Who decides what counts as longevity medicine?

Can we prime skin to regenerate better?

The longevity trap

Why menopause is a muscle-health inflection point

What if aging research has been studying the wrong sex?

‘Aging clocks are tools – not verdicts’

One ‘bad’ fat is making longevity researchers think twice

The second patient in the room

‘Rebuilding the human immune system is possible’

The implementation gap

Energy Span reframes fatigue as early warning

From hacks to health: why biohacking is growing up

Osteoboost raises $8m to scale bone wearable

Rubedo: the senolytic alchemist of aging biology

Gut health, autoimmunity and the diet dilemma

What animals can teach us about reversing age-related disease

Curve Bio strengthens clinical push with CMO hire

Biological clocks age within a day without you aging!

Can medicine outrun aging? Gerontologist says odds are improving

Longevity biotech investment 2026: we’re set for a breakout year

NLRP3: the inflammation master switch – a DLT Chatbot guide

Longevity.Technology has quietly become an AI company

‘Peak performance’ culture is exhausting our nervous systems

The mouth-body connection: why oral health matters for longevity

Longevity law finds its footing

How billionaires die

AI’s role in the next era of longevity biotech

Listening to biology’s early whispers

The regulatory path for rescheduling psychedelics for healthspan

Intervene Immune puts thymus regeneration back in the spotlight

Longevity’s biggest bottleneck is economic

Gordian Bio inks obesity research collab with Pfizer

Asking AI who leads AI for longevity

PEMF therapy – a catalyst for repair and recovery

Why we age is still longevity’s biggest question

The latest longevity science, investment, innovation and insight, delivered every morning.

Unlock Longevity Biotech Report for FREE

  • $617BN - Annual global revenue by 2045
  • $30BN+ - Invested in under 2 years
  • 3,036 - Therapeutics individually assessed